» Authors » Rebekah W Moehring

Rebekah W Moehring

Explore the profile of Rebekah W Moehring including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 81
Citations 985
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Margolin E, Barquin D, Moehring R, Antonelli J, Lipkin M, et al.
J Endourol . 2025 Feb; PMID: 39925120
Urine cultures are routinely used to inform preoperative antibiotic choice and duration prior to endourologic surgery. The presence of mixed flora in preoperative urine cultures holds unclear clinical significance. This...
2.
Turner N, Grambow S, Polage C, Kuhar D, Kutty P, Moehring R, et al.
Clin Infect Dis . 2025 Jan; PMID: 39828613
Importance: The natural history of C. difficile progression in nucleic acid amplification test (NAAT) positive, toxin enzyme immunoassay-negative patients remains poorly described. Better understanding risk for subsequent disease may improve...
3.
Fabre V, Hsu Y, Carroll K, Salinas A, Gadala A, Bower C, et al.
JAMA Netw Open . 2025 Jan; 8(1):e2454738. PMID: 39813030
Importance: Blood culture (BC) use benchmarks in US hospitals have not been defined. Objective: To characterize BC use in adult intensive care units (ICUs) and wards in US hospitals. Design,...
4.
Fabre V, Cosgrove S, Milstone A, Salinas A, Degnan K, Gettler E, et al.
Infect Control Hosp Epidemiol . 2024 Dec; :1-9. PMID: 39703070
Objective: To understand healthcare workers' (HCWs) beliefs and practices toward blood culture (BCx) use. Design: Cross-sectional electronic survey and semi-structured interviews. Setting: Academic hospitals in the United States. Participants: HCWs...
5.
Kim T, Moehring R, Turner N, Ashley E, Crane L, Padgette P, et al.
Infect Control Hosp Epidemiol . 2024 Dec; 1-7. PMID: 39624024
Background: Carbapenem-resistant (CRE) are an urgent threat to healthcare, but the epidemiology of these antimicrobial-resistant organisms may be evolving in some settings since the COVID-19 pandemic. An updated analysis of...
6.
Kwon J, Advani S, Branch-Elliman W, Braun B, Cheng V, Chiotos K, et al.
Infect Control Hosp Epidemiol . 2024 Oct; 1-18. PMID: 39448369
No abstract available.
7.
Deri C, Moehring R, Turner N, Spivey J, Advani S, Wrenn R, et al.
Antimicrob Steward Healthc Epidemiol . 2024 Oct; 4(1):e158. PMID: 39371441
Objective: We aimed to determine whether automated identification of antibiotic targeting suspected urinary tract infection (UTI) shortened the time to antimicrobial stewardship (AS) intervention. Design: Retrospective before-and-after study. Setting: Tertiary...
8.
Perez R, Hayes J, Winters A, Wrenn R, Moehring R
Antimicrob Steward Healthc Epidemiol . 2024 Apr; 4(1):e51. PMID: 38655017
We performed a knowledge, attitudes, and practice (KAP) survey of bedside nurses to evaluate perceptions of antimicrobial use and aid in the design of nursing-based antimicrobial stewardship interventions. The survey...
9.
Perez R, Yarrington M, Deri C, Smith M, Hayes J, Wrenn R, et al.
Open Forum Infect Dis . 2024 Apr; 11(4):ofae141. PMID: 38577030
Background: Advanced practice providers (APPs) have taken on increasing responsibilities as primary team members in acute care hospitals, but the impact of this practice shift on antimicrobial prescribing and infectious...
10.
Wrenn R, Slaton C, Diez Sr T, Turner N, Yarrington M, Anderson D, et al.
Infect Control Hosp Epidemiol . 2024 Feb; 45(6):733-739. PMID: 38347810
Objective: To determine whether removal of default duration, embedded in electronic prescription (e-script), influenced antibiotic days of therapy. Design: Interrupted time-series analysis. Setting: The study was conducted across 2 community...